Adam Savitz - Feb 5, 2025 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
Stock symbol
ANRO
Transactions as of
Feb 5, 2025
Transactions value $
$0
Form type
4
Date filed
2/7/2025, 04:21 PM
Previous filing
Jul 11, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANRO Employee Stock Option (Right to Buy) Award $0 +76K $0.00 76K Feb 5, 2025 Common Stock 76K $4.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option shall vest on February 5, 2026, and one forty-eighth (1/48th) of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.